Aristo Bio-Tech And Lifescience Limited — Others, 29-05-2025: Appointment

Aristo Bio-Tech and Lifescience Limited has announced a board meeting on the approval of the financial results for the quarter and half-year. The board approved the audited standalone financial results for the year, reporting a net profit of Rs. 4.06 Cr, up from Rs. 3.90 Cr the previous year, and proposed a final dividend of Rs. 0.50 per equity share (5%). The company appointed Ms. Diksha Jaiprakash Peswani as Company Secretary & Compliance Officer, following the resignation of Mrs. Ayushi Aditya Deora. The business continues focusing on manufacturing and supplying agrochemical formulations.